These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 19821716)

  • 1. Formulation and characterization of bufadienolides-loaded nanostructured lipid carriers.
    Li F; Wang Y; Liu Z; Lin X; He H; Tang X
    Drug Dev Ind Pharm; 2010 May; 36(5):508-17. PubMed ID: 19821716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy and safety of bufadienolides-loaded nanostructured lipid carriers.
    Li F; Weng Y; Wang L; He H; Yang J; Tang X
    Int J Pharm; 2010 Jun; 393(1-2):203-11. PubMed ID: 20385221
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production and characterization of testosterone undecanoate-loaded NLC for oral bioavailability enhancement.
    Muchow M; Maincent P; Müller RH; Keck CM
    Drug Dev Ind Pharm; 2011 Jan; 37(1):8-14. PubMed ID: 21138344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docetaxel-nicotinamide complex-loaded nanostructured lipid carriers for transdermal delivery.
    Fan X; Chen J; Shen Q
    Int J Pharm; 2013 Dec; 458(2):296-304. PubMed ID: 24177313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro characterization and growth inhibition effect of nanostructured lipid carriers for controlled delivery of methotrexate.
    Abdelbary G; Haider M
    Pharm Dev Technol; 2013; 18(5):1159-68. PubMed ID: 21958084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preparation and characterization of nanostructured lipid carriers loaded traditional Chinese medicine, zedoary turmeric oil.
    Zhao XL; Yang CR; Yang KL; Li KX; Hu HY; Chen DW
    Drug Dev Ind Pharm; 2010 Jul; 36(7):773-80. PubMed ID: 20136496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimisation of the formulation of β-carotene loaded nanostructured lipid carriers prepared by solvent diffusion method.
    Hejri A; Khosravi A; Gharanjig K; Hejazi M
    Food Chem; 2013 Nov; 141(1):117-23. PubMed ID: 23768336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical characterization and in vivo bioluminescence imaging of nanostructured lipid carriers for targeting the brain: apomorphine as a model drug.
    Hsu SH; Wen CJ; Al-Suwayeh SA; Chang HW; Yen TC; Fang JY
    Nanotechnology; 2010 Oct; 21(40):405101. PubMed ID: 20823498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Formulating fluticasone propionate in novel PEG-containing nanostructured lipid carriers (PEG-NLC).
    Doktorovová S; Araújo J; Garcia ML; Rakovský E; Souto EB
    Colloids Surf B Biointerfaces; 2010 Feb; 75(2):538-42. PubMed ID: 19879736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development, evaluation and clinical studies of Acitretin loaded nanostructured lipid carriers for topical treatment of psoriasis.
    Agrawal Y; Petkar KC; Sawant KK
    Int J Pharm; 2010 Nov; 401(1-2):93-102. PubMed ID: 20858539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physicochemical properties of nevirapine-loaded solid lipid nanoparticles and nanostructured lipid carriers.
    Kuo YC; Chung JF
    Colloids Surf B Biointerfaces; 2011 Apr; 83(2):299-306. PubMed ID: 21194902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nanostructured lipid (NLCs) carriers as a bioavailability enhancement tool for oral administration.
    Gaba B; Fazil M; Ali A; Baboota S; Sahni JK; Ali J
    Drug Deliv; 2015; 22(6):691-700. PubMed ID: 24670099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the in vitro differential protein adsorption patterns of didanosine-loaded nanostructured lipid carriers (NLCs) for potential targeting to the brain.
    Kasongo KW; Jansch M; Müller RH; Walker RB
    J Liposome Res; 2011 Sep; 21(3):245-54. PubMed ID: 21174528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Encapsulation of ascorbyl palmitate in nanostructured lipid carriers (NLC)--effects of formulation parameters on physicochemical stability.
    Teeranachaideekul V; Müller RH; Junyaprasert VB
    Int J Pharm; 2007 Aug; 340(1-2):198-206. PubMed ID: 17482778
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An improved method for the preparations of nanostructured lipid carriers containing heat-sensitive bioactives.
    Hung LC; Basri M; Tejo BA; Ismail R; Nang HL; Abu Hassan H; May CY
    Colloids Surf B Biointerfaces; 2011 Oct; 87(1):180-6. PubMed ID: 21652183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications.
    Araújo J; Gonzalez-Mira E; Egea MA; Garcia ML; Souto EB
    Int J Pharm; 2010 Jun; 393(1-2):167-75. PubMed ID: 20362042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of protocol for screening the formulation components and the assessment of common quality problems of nano-structured lipid carriers.
    Negi LM; Jaggi M; Talegaonkar S
    Int J Pharm; 2014 Jan; 461(1-2):403-10. PubMed ID: 24345574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preparation of nanostructured lipid carriers loaded with supercritical carbon dioxide fluid extraction of Xionggui powder].
    Chen Y; Chen F; Wei W; Zhang X; Feng Q; Jin R
    Zhongguo Zhong Yao Za Zhi; 2009 Jan; 34(2):148-51. PubMed ID: 19385172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nanostructured lipid carriers (NLCs) for drug delivery and targeting.
    Fang CL; Al-Suwayeh SA; Fang JY
    Recent Pat Nanotechnol; 2013 Jan; 7(1):41-55. PubMed ID: 22946628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fate of nanostructured lipid carriers (NLCs) following the oral route: design, pharmacokinetics and biodistribution.
    Beloqui A; Solinís MÁ; Delgado A; Evora C; Isla A; Rodríguez-Gascón A
    J Microencapsul; 2014; 31(1):1-8. PubMed ID: 23631381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.